Edward C. Li, PharmD, MPH, BCOP

Associate Professor of Pharmacy Practice, University of New England College of Pharmacy, Portland, ME

Authored Items

The ASCO Value Framework: To What End?

July 2015, Vol 6, No 6 - VBCC Perspectives

In the modern era of increasing healthcare costs, and with prescription drug expenditures forecasted to increase by 7% to 9% in the next year, a focused discussion on the value proposition of cancer care is warranted. The American Society of Clinical Oncology (ASCO) Value in Cancer Care Task Force should be commended for igniting the conversation about the value of chemotherapy regimens. We live in a society with a limited amount of resources, and, therefore, resources such as treatment options must be allocated appropriately to maximize the benefits to society. [ Read More ]